Literature DB >> 17870271

Infection in systemic lupus erythematosus.

M Khalifa1, N Kaabia, F Bahri, E Ben Jazia, E Bouajina, A Omezzine Letaief.   

Abstract

BACKGROUND: Infections are common in patients with systemic lupus erythematosus (SLE) throughout the course of their disease and remain a source of mortality. The aim of this study was to determine the prevalence of infections, to describe their nature, and analyze their risk factors in adults with SLE. PATIENTS AND METHODS: We performed a descriptive study, at the Farhat-Hached Hospital in Sousse, and retrospectively analyzed the charts of 75 patients with SLE seen between 1990 and 2004. The group of patients with documented infections was compared to a control group. A logistic regression analysis was performed to determine risk factors associated with infection.
RESULTS: Our study included 64 women and 11 men (median age of 31.4 years). Forty-three patients (57.5%) had 82 infectious episodes: 23 patients had at least two infectious episodes. Most infections were community acquired, and 80% were severe. The most common infections involved the urinary tract (28%), the skin and soft tissue (26.8%), and the respiratory tract (18.3%). Documented pathogens were: 45 common bacteria, 11 Candida albicans and four Mycobacterium tuberculosis. Localized herpes zoster was noted in three cases. Factors associated with infection, found in univariate analysis, were renal involvement, serum albumin lower than 25 g/l, and corticosteroids treatment. Only corticosteroids therapy remained statistically significant after multivariate analysis.

Entities:  

Mesh:

Year:  2007        PMID: 17870271     DOI: 10.1016/j.medmal.2007.07.003

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  3 in total

1.  Anti-Saccharomyces cerevisiae antibodies in patients with systemic lupus erythematosus.

Authors:  Amani Mankaï; Wahiba Sakly; Yosra Thabet; Achouak Achour; Wiem Manoubi; Ibtissem Ghedira
Journal:  Rheumatol Int       Date:  2012-04-10       Impact factor: 2.631

2.  Incidence and risk of infection in egyptian patients with systemic lupus erythematosus.

Authors:  Dalia F Mohamed; Reem A Habeeb; Sherin M Hosny; Shafika E Ebrahim
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2014-07-30

3.  Infections and systemic lupus erythematosus.

Authors:  Thelma Larocca Skare; Jéssica Scherer Dagostini; Patricia Imai Zanardi; Renato Mitsunori Nisihara
Journal:  Einstein (Sao Paulo)       Date:  2016 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.